What happened
Masimo of Irvine, California, makes the SafetyNet Opioid System, a wearable pulse oximeter with Opioid Halo software. The software watches oxygen saturation, pulse rate and perfusion for patterns of opioid-induced respiratory depression and raises three levels of alarm. The top level can trigger a call from emergency dispatch. Masimo analyzed 40,322 data segments from 641 people using prescription, hospital or illicit opioids. FDA reviewers report that Opioid Halo matched the sensitivity of an oximeter alarm with a fixed threshold, with higher specificity. Non-actionable alarms fell by 89% at Level 2 and 96.7% at Level 3. Level 3 was less sensitive than the comparator for hospital and illicit users. FDA granted the De Novo request on 31 March 2023. FDA describes Opioid Halo as software that detects risk from patterns in oxygenation data, without mention of machine learning.
Sources
-
Regulatory document, by authors with no tie to the system.
U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31.
The analysis found equivalent sensitivity as a system with a higher specificity in the detection of OIRD as compared to a pulse oximeter with a fixed threshold alarm.
Details
AI system
- Workflow
-
A finger sensor fed oxygen saturation, pulse rate and perfusion index to the software. Alarms escalated from the user to emergency contacts and then to emergency dispatch.
Follow-up
- Conditions for replication
-
The user is 15 or older and is on no more than 2.0 L/min of supplemental oxygen. Use is supervised by people aware of countermeasures such as naloxone.
Entry details
- Sector
-
Healthcare.
- Purpose
-
Masimo built the SafetyNet Opioid System to monitor people using opioids at home or in hospital and alarm when their oxygenation shows signs of opioid-induced respiratory depression.
Not yet checked: model, release, provider, role, configuration, inputs and outputs, autonomy, human oversight, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.
Cite this record
Peter H. Vartanian. (2026). Opioid Halo cut non-actionable alarms in opioid overdose monitoring (AIBD-0777). Artificial Intelligence Benefits Database, edition of 31 October 2026. https://petervartanian.xyz/aibd/records/AIBD-0777.html (archived at https://doi.org/10.7910/DVN/AADSII, version 4.0)